A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This is a randomized, double-blind, placebo-controlled study that will investigate the safety and clinical activity of a single intravenous (IV) dose of MHAA4549A in adult participants hospitalized with severe influenza A in combination with oseltamivir versus a comparator arm of placebo with oseltamivir.
Epistemonikos ID: 69f643c502f94a997debb3f2581426dd41a6fe5a
First added on: May 12, 2024